Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 4/2013

01-12-2013 | Original Paper

Prognostic factors of work disability in sick-listed cancer survivors

Authors: Peter van Muijen, Saskia F. A. Duijts, Allard J. van der Beek, Johannes R. Anema

Published in: Journal of Cancer Survivorship | Issue 4/2013

Login to get access

Abstract

Purpose

Sick-listed cancer survivors may face lasting side-effects, even after a successful completion of treatment. As a consequence, they are at risk of work disability, which may lead to job loss. Knowledge of prognostic factors of work disability may support cancer survivors in their trajectory of vocational rehabilitation. The purpose of this study was to identify prognostic factors of work disability in sick-listed cancer survivors.

Methods

From the first day of sick leave, a cohort of 131 cancer survivors was followed for 24 months. Included participants were aged between 20 and 63 years. Data were collected, using questionnaires, at 10 months after reporting sick. The level of work disability, i.e., entitlement for disability compensation, was assessed by an insurance physician and a labour expert at 24 months. Univariate and multiple logistic regression analyses were performed.

Results

In the univariate analysis, 14 variables were found to be associated with the level of work disability at 24 months. These factors were related to socio-demographics, health characteristics, work-related characteristics, and return to work (RTW) expectations. Multiple logistic regression showed that at 10-month sick leave, perception of health care providers on cancer survivors’ work ability and experienced influence on RTW, both reported by workers, were significantly associated with the level of work disability at 24 months.

Conclusion

It seems in the interest of cancer survivors to take an active role in planning their RTW trajectory and to discuss RTW with their health care providers.

Implications for Cancer Survivors

The potential role healthcare providers may play in counselling cancer survivors on RTW must not be underestimated. Cancer survivors may benefit in having control on their RTW trajectory.
Literature
1.
Pryce J, Munir F, Haslam C. Cancer survivorship and work: symptoms, supervisor response, co-worker disclosure and work adjustment. J Occup Rehabil. 2007;17(1):83–92.PubMedCrossRef
2.
Short PF, Vasey JJ, Moran JR. Long-term effects of cancer survivorship on the employment of older workers. Health Serv Res. 2008;43:193–210.CrossRef
3.
Gudbergsson SB, Dahl AA. Aspects of the work situation of cancer survivors. Minerva Psichiatr. 2008;49(1):45–60.
4.
5.
Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–92.PubMedCrossRef
6.
Signaleringscommissie Kanker. Kanker in Nederland tot 2020, trends en prognoses. 2011 (in Dutch).
7.
Spelten ER, Verbeek JHAM, Uitterhoeve ALJ, et al. Cancer, fatigue and the return of patients to work-a prospective cohort study. Eur J Cancer. 2003;39(11):1562–7.PubMedCrossRef
8.
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol Hematol. 2011;77(2):109–30.PubMedCrossRef
9.
Kenniscentrum UWV Directie SBK. UWV Kwartaal Verkenning 2010 III, 2010 (in Dutch).
10.
van Muijen P, Weevers NLEC, Snels IAK, et al. Predictors of return to work and employment in cancer survivors: a systematic review. Eur J of Cancer Care. 2013;22(2):144–60.CrossRef
11.
Wet werk en inkomen naar arbeidsvermogen. Staatscourant 2005;572 (in Dutch)
12.
Schuring M, Robroek SJ, Otten FW, Arts CH, Burdorf A. The effect of ill health and socioeconomic status on labor force exit and re-employment: a prospective study with ten years follow-up in the Netherlands. Scand J Work Environ Health doi:10.​5271/​sjweh.​3321
13.
de Jong P, Bruinsma H, Aarts L, Hop J. Determinanten van WAO-toetreding: een eerste totaalbeeld. Zoetermeer: Sociale Verzekeringsraad; 1981 (in Dutch).
14.
Amir Z, Brocky J. Cancer survivorship and employment: epidemiology. Occup Med. 2009;59(6):373–7.CrossRef
15.
Verbeek J, Spelten E, Kammeijer M, Sprangers M. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med. 2003;60(5):352–7.PubMedCrossRef
16.
de Jong P, Veerman T, van der Burg C. Schrijvershof C. Den Haag: Nederland is niet ziek meer; 2009 (in Dutch).
17.
Molenaar-Cox P, van der Giezen A, Jehoel-Gijsbers G. Long-term disability in 1999. Amsterdam: Landelijk Instituut Sociale Verzekeringen; 2000 (in Dutch).
18.
Molenaar-Cox P, Fiseler J, van der Stelt H, Smaal M, Kers W. Data book PES-3: the final responsibility of design and operation of research on the position of the disabled client. The Netherlands: Ministry of Social Affairs and Employment; 1995.
19.
Buckwalter AE, Karnell LH, Smith RB, Christensen AJ, Funk GF. Patient-reported factors associated with discontinuing employment following head and neck cancer treatment. Arch Otolaryngol Head Neck Surg. 2007;133(5):464–70.PubMedCrossRef
20.
Choi KS, Kim EJ, Lim JH, et al. Job loss and reemployment after a cancer diagnosis in Koreans—a prospective cohort study. Psycho-oncology. 2007;16(3):205–13.PubMedCrossRef
21.
Johnsson A, Fornander T, Olsson M. Factors associated with return to work after breast cancer treatment. Acta Oncol. 2007;46(1):90–6.PubMedCrossRef
22.
Lauzier S, Maunsell E, Drolet M, et al. Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Nat Cancer Inst. 2008;100(5):321–32.PubMedCrossRef
23.
Oberst K, Bradley CJ, Gardiner JC, Schenk M, Given CW. Work task disability in employed breast and prostate cancer patients. J Cancer Surviv. 2010;4(4):322–30.PubMedCrossRef
24.
van den Brink M, van den Hout WB, Kievit J, et al. The impact of diagnosis and treatment of rectal cancer on paid and unpaid labour. Dis Colon Rectum. 2005;48(10):1875–82.PubMedCrossRef
25.
Verbeek J, Spelten E, Kammeijer M, Sprangers M. Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physicians. Occup Environ Med. 2003;60(5):352–7.PubMedCrossRef
26.
Grewal R, Cote JA, Baumgartner H. Multicollinearity and measurement error in structural equition models; implications for theory testing. Marketing Science. 2004;23(4):519–29.CrossRef
27.
28.
Balak F, Roelen CAM, Koopmans PC, Ten Berge EE, Groothoff JW. Return to work after early-stage breast cancer: a cohort study into the effects of treatment and cancer-related symptoms. J Occup Rehabil. 2008;18(3):267–72.PubMedCrossRef
29.
Bergman B, Sorenson S. Return to work among patients with small cell lung cancer. Eur J Respir Dis. 1987;70(1):49–53.PubMed
30.
Borget I, Corone C, Nocaudie M, et al. Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with thyrogen and thyroid hormone withdrawal. Eur J Endocrinol. 2007;156(5):531–8.PubMedCrossRef
31.
Bouknight RR, Bradley CJ, Luo Z. Correlates of return to work for breast cancer survivors. J Clin Oncol. 2006;24(3):345–53.PubMedCrossRef
32.
Bradley CJ, Oberst K, Schenk M. Absenteeism from work: the experience of employed breast and prostate cancer patients in the months following diagnosis. Psycho-oncology. 2006;15(8):739–47.PubMedCrossRef
33.
Eaker S, Wigertz A, Lambert PC, Bergkvist L, Ahlgren J, Lambe M. Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis. PLoS ONE. 2011;6:e18040.PubMedCrossRef
34.
Fiva JH, Haegeland T, Ronning M. Health status after cancer: does it matter which hospital you belong to? BMC Health Serv Res. 2010;10:204.PubMedCrossRef
35.
Hewitt M, Rowland JH, Yancik R. Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci. 2003;58(1):82–91.PubMedCrossRef
36.
Kornblith AB, Huang HQ, Walker JL, Spirtos NM, Rotmensch J, Cella D. Quality of life of patients with endometrial cancer undergoing laparoscopic International Federation of gynaecology and obstetrics staging compared with laparotomy: a Gynaecologic Oncology Group study. J Clin Oncol. 2009;27(32):5337–42.PubMedCrossRef
37.
Park JH, Park EC, Park JH, Kim SG, Lee SY. Job loss and re-employment of cancer patients in Korean employees: a nationwide retrospective cohort study. J Clin Oncol. 2008;26(8):1302–9.PubMedCrossRef
38.
Roelen CA, Koopmans PC, Groothoff JW, van der Klink JJ, Bultmann U. Sickness absence and full return to work after cancer: 2-year follow-up of register data for different cancer sites. Psycho-oncology. 2011;20:1001–6.PubMed
39.
Sjovall K, Attner B, Englund M, et al. Sickness absence among cancer patients in the pre-diagnostic and the post-diagnostic phases of five common forms of cancer. Support Care Cancer. 2011;10:741–7.
40.
Sultan R, Slova D, Thiel B, Lepor H. Time to return to work and physical activity following open radical retropubic prostatectomy. J Urol. 2006;176:1420–3.PubMedCrossRef
41.
Taskila-Brandt T, Martikainen R, Virtanen SV, Pukkala E, Hietanen P, Lindbohm ML. The impact of education and occupation on the employment status of cancer survivors. Eur J Cancer. 2004;40(16):2488–93.PubMedCrossRef
42.
Ahn E, Cho J, Shin DW, et al. Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat. 2009;116(3):609–16.PubMedCrossRef
43.
Bednarek HL, Bradley CJ. Work and retirement after cancer diagnosis. Res Nurs Health. 2005;28(2):126–35.PubMedCrossRef
44.
Yabroff KR, Lawrence WF, Clauser S, Davis WW, Brown ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.PubMedCrossRef
45.
Werner EL, Cote P. Low back pain and determinants of sickness absence. Eur J Gen Pract. 2009;15(2):74–9.PubMedCrossRef
46.
Dunner S, Decrey H, Burnand B, Pecoud A. Sickness certification in primary care. Soz Praventivmed. 2001;46(6):389–95.PubMedCrossRef
47.
Echevarria-Zuno S, Mar-Obeso AJ, Borja-Aburto VH, Mendez-Bueno FJ, Guilar-Sanchez L, Rascon-Pacheco RA. Sickness absence certification from the medical perspective. Rev Med Inst Mex Seguro Soc. 2009;47(5):565–74.PubMed
48.
Englund L, Svardsudd K. Sick-listing habits among general practitioners in a Swedish county. Scand J Prim Health Care. 2000;18(2):81–6.PubMedCrossRef
49.
Gonzalez-Barcala FJ, Cadarso-Suarez C, Valdes-Cuadrado L, et al. Factors determining the duration of temporary disability and return to work in a health district of Galicia. Aten Primaria. 2006;37(8):431–6.PubMed
50.
Reiso H, Gulbrandsen P, Brage S. Doctors’ prediction of certified sickness absence. Fam Pract. 2004;21(2):192–8.PubMedCrossRef
51.
Carlsen K, Dalton SO, Diderichsen F, Johansen C. Risk for unemployment of cancer survivors: A Danish cohort study. Eur J Cancer. 2008;44(13):1866–74.PubMedCrossRef
52.
Ohguri T, Narai R, Funahashi A, Nishiura C, Yamashita T, Yarita K. Limitations on work and attendance rates after employees with cancer returned to work at a single manufacturing company in Japan. Occup Health. 2009;46:267–72.CrossRef
53.
Short PF, Vasey JJ, Tunceli K. Employment pathways in a large cohort of adult cancer survivors. Cancer. 2005;103(6):1292–301.PubMedCrossRef
54.
Short PF, Vasey JJ, Belue R. Work disability associated with cancer survivorship and other chronic conditions. Psycho-oncology. 2008;17(1):91–7.PubMedCrossRef
Metadata
Title
Prognostic factors of work disability in sick-listed cancer survivors
Authors
Peter van Muijen
Saskia F. A. Duijts
Allard J. van der Beek
Johannes R. Anema
Publication date
01-12-2013
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 4/2013
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-013-0297-3

Other articles of this Issue 4/2013

Journal of Cancer Survivorship 4/2013 Go to the issue

OriginalPaper

The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry

OriginalPaper

Health-related quality of life in young men with testicular cancer: validation of the Cancer Assessment for Young Adults (CAYA)

OriginalPaper

Health-related quality of life in survivors of childhood cancer: the role of chronic health problems

OriginalPaper

Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study

Review

A qualitative synthesis of trials promoting physical activity behaviour change among post-treatment breast cancer survivors

OriginalPaper

Validity of self-reported genetic counseling and genetic testing use among breast cancer survivors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits